MBL-associated serine proteases (MASPs) and infectious diseases

Molecular Immunology

Volumn 67, Issue 1, 2015, Pages 85-100

  Beltrame, Marcia H ^a   Boldt, Angelica B W ^a   Catarino, Sandra J ^a   Mendes, Hellen C ^a   Boschmann, Stefanie E ^a   Goeldner, Isabela ^a   Messias Reason, Iara ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Complement system; MAp19; MAp44; MASP 1; MASP 2; MASP 3

Indexed keywords

LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MAP19 PROTEIN; MASP PROTEIN 1; MASP PROTEIN 2; MASP PROTEIN 3; MICROTUBULE ASSOCIATED PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT; MANNOSE BINDING LECTIN; MASP1 PROTEIN, HUMAN; MASP2 PROTEIN, HUMAN;

BACTERIAL INFECTION; CHAGAS DISEASE; ENDOGENOUS RETROVIRUS; ENZYME BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN T-LYMPHOTROPIC VIRUS 1; LEPROSY; MALARIA; META ANALYSIS (TOPIC); NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROTOZOAL INFECTION; PSEUDOMONAS INFECTION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STREPTOCOCCUS INFECTION; TUBERCULOSIS; VIRUS INFECTION; COMPLEMENT LECTIN PATHWAY; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PARASITOLOGY; PATHOLOGY; VIROLOGY;

BACTERIA (MICROORGANISMS); PROTOZOA;

BACTERIAL INFECTIONS; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; COMPLEMENT SYSTEM PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MANNOSE-BINDING LECTIN; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; POLYMORPHISM, GENETIC; PROTOZOAN INFECTIONS; SIGNAL TRANSDUCTION; VIRUS DISEASES;

EID: 84936986296     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.03.245     Document Type: Review

References (199)

1. Abbas A.K., Lichtman A.H., Pillai S. Cellular and Molecular Immunology 2012, EUA: Sauders Elsevier Inc. 7 ed.
2. Aiello V.D., Reis M.M., Benvenuti L.A., Higuchi M.D.L., Ramires J.A.F., Halperin J.a A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy. J. Pathol. 2002, 197:224-229. 10.1002/path.1095.
3. Ali Y.M., Lynch N.J., Haleem K.S., Fujita T., Endo Y., Hansen S., Holmskov U., Takahashi K., Stahl G.L., Dudler T., Girija U.V., Wallis R., Kadioglu A., Stover C.M., Andrew P.W., Schwaeble W.J. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog. 2012, 8:e1002793. 10.1371/journal.ppat.1002793.
4. Alves Pedroso M.L., Boldt a.B.W., Pereira-Ferrari L., Steffensen R., Strauss E., Jensenius J.C., Ioshii S.O., Messias-Reason I. Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy. Clin. Exp. Immunol. 2008, 152:258-264. 10.1111/j.1365-2249.2008.03614.x.
5. Ambrosio A.R., De Messias-Reason I.J.T. Leishmania (Viannia) braziliensis: interaction of mannose-binding lectin with surface glycoconjugates and complement activation. An antibody-independent defence mechanism. Parasite Immunol. 2005, 27:333-340. 10.1111/j.1365-3024.2005.00782.x.
6. Ambrus G., Gál P., Kojima M., Szilágyi K., Balczer J., Antal J., Gráf L., Laich A., Moffatt B.E., Schwaeble W., Sim R.B., Závodszky P., Gal P., Kojima M., Szilagyi K., Balczer J., Antal J., Graf L., Laich A., Moffatt B.E., Schwaeble W., Sim R.B., Zavodszky P. Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments. J. Immunol. 2003, 170:1374-1382. 10.4049/jimmunol.170.3.1374.
7. Ameye L., Paesmans M., Thiel S., Jensenius J.C., Aoun M. M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy. Clin. Exp. Immunol. 2012, 167:303-308. 10.1111/j.1365-2249.2011.04512.x.
8. Ammitzbøll C.G., Steffensen R., Nielsen H.J., Thiel S., Stengaard-Pedersen K., Bøgsted M., Jensenius J.C. Polymorphisms in the MASP1 gene are associated with serum levels of MASP-1, MASP-3, and MAp44. PLOS ONE 2013, 8:e73317. 10.1371/journal.pone.0073317.
9. Anders E.M., Hartley C.a., Jackson D.C. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4485-4489. 10.1073/pnas.87.12.4485.
10. Banda N.K., Takahashi M. Essential role of complement mannose-binding lectin-associated serine proteases-1/3 in the murine collagen antibody-induced model of inflammatory arthritis. J. Immunol. 2010, 185:5598-5606. 10.4049/jimmunol.1001564.Essential.
11. Banda N.K., Mehta G., Kjaer T.R., Takahashi M., Schaack J., Morrison T.E., Thiel S., Arend W.P., Holers V.M. Essential role for the lectin pathway in collagen antibody-induced arthritis recealed through use of adenovirus programming complement inhibitor MAp44 expression. J. Immunol. 2014, 193:2455-2468. 10.4049/jimmunol.1400752.
12. Barth H., Liang T.J., Baumert T.F. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006, 44:527-535. 10.1002/hep.21321.
13. Blackham S., Baillie A., Al-Hababi F., Remlinger K., You S., Hamatake R., McGarvey M.J. Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus. J. Virol. 2010, 84:5404-5414. 10.1128/JVI.02529-09.
14. Boldt A.B., Goeldner I., Stahlke E.R.S., Thiel S., Jensenius J.C., de Messias-Reason I.J.T. Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 Exon 5. PLOS ONE 2013, 8:e69054. 10.1371/journal.pone.0069054.
15. Boldt A.B., Luty A., Grobusch M., Dietz K., Dzeing A., Kombila M., Kremsner P., Kun J. Association of a new mannose-binding lectin variant with severe malaria in Gabonese children. Genes Immun. 2006, 7:393-400. 10.1038/sj.gene.6364312.
16. Boldt A.B., Sanchez M.I.N., Stahlke E.R.S., Steffensen R., Thiel S., Jensenius J.C., Prevedello F.C., Mira M.T., Kun J.F.J., Messias-Reason I.J.T. Susceptibility to leprosy is associated with M-ficolin polymorphisms. J. Clin. Immunol. 2013, 33:210-219. 10.1007/s10875-012-9770-4.
17. Boldt A.B., Luz P.R., Messias-Reason I.J.T. MASP2 haplotypes are associated with high risk of cardiomyopathy in chronic Chagas disease. Clin. Immunol. 2011, 140:63-70. 10.1016/j.clim.2011.03.008.
18. Boldt A.B., Messias-Reason I.J., Lell B., Issifou S., Pedroso M.L.A., Kremsner P.G., Kun J.F. Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection. Malar. J. 2009, 8:97. 10.1186/1475-2875-8-97.
19. Boldt A.B., Goeldner I., Messias-Reason I.J.T. Relevance of the lectin pathway of complement in rheumatic diseases. Adv. Clin. Chem. 2012, 56. 10.1016/B978-0-12-394317-0.00012-1.
20. Boldt A.B., Grisbach C., Steffensen R., Thiel S., Kun J., Jensenius J., Messias-Reason I. Multiplex sequence-specific polymerase chain reaction reveals new MASP2 haplotypes associated with MASP-2 and MAp19 serum levels. Hum. Immunol. 2011, 72:753-760. 10.1016/j.humimm.2011.05.015.
21. Bonte L.R.La, Pavlov V.I., Tan Y.S., Takahashi K., Takahashi M., Banda N.K., Zou C., Fujita T., Stahl G.L. MBL-associated serine protease -1 (MASP-1) is a significant contributor to coagulation in a murine model of occusive thrombosis. J. Immunol. 2012, 188:885-891. 10.4049/jimmunol.1102916.MBL-Associated.
22. Brown E.J., Hosea S.W., Hammer C.H., Burch C.G. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J. Clin. Invest. 1982, 69:85-98.
23. Brown J.S., Hussell T., Gilliland S.M., Holden D.W., Paton J.C., Ehrenstein M.R., Walport M.J., Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16969-16974. 10.1073/pnas.012669199.
24. Brown K.S., Keogh M.J., Owsianka A.M., Adair R., Patel A.H., Arnold J.N., Ball J.K., Sim R.B., Tarr A.W., Hickling T.P. Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry. Protein Cell 2010, 1:664-674. 10.1007/s13238-010-0088-9.
25. Brown K.S., Keogh M.J., Tagiuri N., Grainge M.J., Presanis J.S., Ryder S.D., Irving W.L., Ball J.K., Sim R.B., Hickling T.P. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex. Clin. Exp. Immunol. 2007, 147:90-98. 10.1111/j.1365-2249.2006.03264.x.
26. Carlsson M., Sjöholm a.G., Eriksson L., Thiel S., Jensenius J.C., Segelmark M., Truedsson L. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin. Exp. Immunol. 2005, 139:306-313. 10.1111/j.1365-2249.2004.02690.x.
27. Catarino S.J.S., Boldt A.B., Beltrame M.H., Nisihara R.M., Schafranski M.D., de Messias-Reason I.J. Association of MASP2 polymorphisms and protein levels with rheumatic fever and rheumatic heart disease. Hum. Immunol. 2014, 75:1197-1202. 10.1016/j.humimm.2014.10.003.
28. Cestari I.D.S., Ansa-Addo E., Deolindo P., Inal J.M., Ramirez M.I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J. Immunol. 2012, 188:1942-1952. 10.4049/jimmunol.1102053.
29. Cestari I.D.S., Ramirez M.I. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PLoS ONE 2010, 5:e9721. 10.1371/journal.pone.0009721.
30. Cestari I.D.S., Evans-osses I., Freitas J.C., Inal J.M., Ramirez M.I. Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi. J. Infect. Dis. 2008, 198:1276-1283. 10.1086/592167.
31. Cestari I.D.S., Krarup A., Sim R.B., Inal J.M., Ramirez M.I. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. Mol. Immunol. 2009, 47:426-437. 10.1016/j.molimm.2009.08.030.
32. Chang C. Cutting edge issues in rheumatic fever. Clin. Rev. Allergy Immunol. 2012, 42:213-237. 10.1007/s12016-011-8271-1.
33. Charchaflieh J., Wei J., Labaze G., Hou Y.J., Babarsh B., Stutz H., Lee H., Worah S., Zhang M. The role of complement system in septic shock. Clin. Dev. Immunol. 2012, 2012:407324. 10.1155/2012/407324.
34. Chatzinikolaou I., Abi-Said D., Bodey G.P., Rolston K.V.I., Tarrand J.J., Samonis G. Recent experience with pseudomonas aeruginosa bacteremia in patients with cancer. Arch. Intern. Med. 2000, 160:501. 10.1001/archinte.160.4.501.
35. Chen M., Daha M.R., Kallenberg C.G.M. The complement system in systemic autoimmune disease. J. Autoimmun. 2010, 34:J276-J286. 10.1016/j.jaut.2009.11.014.
36. Chen M., Deng J., Su C., Li J., Wang M., Abuaku B.K., Hu S., Tan H., Wen S.W. Impact of passive smoking, cooking with solid fuel exposure, and MBL/MASP-2 gene polymorphism upon susceptibility to tuberculosis. Int. J. Infect. Dis. 2014, 29:1-6. 10.1016/j.ijid.2014.08.010.
37. Christensen T., Petersen T., Thiel S., Brudek T., Ellermann-Eriksen S., Møller-Larsen A. Gene-environment interactions in multiple sclerosis: innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway. J. Neuroimmunol. 2007, 183:175-188. 10.1016/j.jneuroim.2006.09.014.
38. Coelho A., Brandão L., Guimarães R., Loureiro P., de Lima Filho J., de Alencar L., Crovellha S., Segat L. Mannose binding lectin and mannose binding lectin-associated serine protease-2 genes polymorphisms in human T-lymphotropic virus infection. J. Med. Virol. 2013, 85:1829-1835. 10.1002/jmv.
39. da Cruz H.L., da Silva R.C., Segat L., de Carvalho M.S., Brandao L.A., Guimarães R.L., Santos F.C., de Lira L.A., Montenegro L.M., Schindler H.C., Crovella S. MBL2 gene polymorphisms and susceptibility to tuberculosis in a northeastern Brazilian population. Infect. Genet. Evol. 2013, 19:323-329.
40. Dahl M.R., Thiel S., Matsushita M., Fujita T., Willis a.C., Christensen T., Vorup-Jensen T., Jensenius J.C. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 2001, 15:127-135.
41. Davidson B., Abeler V.M., Førsund M., Holth A., Yang Y., Kobayashi Y., Chen L., Kristensen G.B., Shih I.-M., Wang T.-L. Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum. Pathol. 2014, 45:691-700. 10.1016/j.humpath.2013.11.003.
42. De Messias-Reason I.J., Kremsner P.G., Kun J.F.J. Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J. Infect. Dis. 2009, 199:801-804. 10.1086/597070.
43. De Messias-Reason I.J., Boldt A.B.W., Moraes Braga A.C., Von Rosen Seeling Stahlke E., Dornelles L., Pereira-Ferrari L., Kremsner P.G., Kun J.F.J. The association between mannan-binding lectin gene polymorphism and clinical leprosy: new insight into an old paradigm. J. Infect. Dis. 2007, 196:1379-1385. 10.1086/521627.
44. Degn S.E., Hansen A.G., Steffensen R., Jacobsen C., Jensenius J.C., Thiel S. MAp44, a human protein associated with pattern recognition molecules of the complement system and regulating the lectin pathway of complement activation. J. Immunol. 2009, 183:7371-7378. 10.4049/jimmunol.0902388.
45. Degn S.E., Jensen L., Gál P., Dobó J., Holmvad S.H., Jensenius J.C., Thiel S. Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system. J. Immunol. Methods 2010, 361:37-50. 10.1016/j.jim.2010.07.006.
46. Degn S.E., Jensen L., Olszowski T., Jensenius J.C., Thiel S. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44. J. Immunol. 2013, 191:1334-1345. 10.4049/jimmunol.1300780.
47. Degn S.E., Kjaer T.R., Kidmose R.T., Jensen L., Hansen A.G., Tekin M., Jensenius J.C., Andersen G.R., Thiel S. Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:13445-13450. 10.1073/pnas.1406849111.
48. Degn S.E., Thiel S. Humoral pattern recognition and the complement system. Scand. J. Immunol. 2013, 78:181-193. 10.1111/sji.12070.
49. Degn S.E., Thiel S., Nielsen O., Hansen A.G., Steffensen R., Jensenius J.C. MAp19, the alternative splice product of the MASP2 gene. J. Immunol. Methods 2011, 373:89-101. 10.1016/j.jim.2011.08.006.
50. Degn S.E., Jensen L., Hansen A.G., Duman D., Tekin M., Jensenius J.C., Thiel S. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J. Immunol. 2012, 189:3957-3969. 10.4049/jimmunol.1201736.
51. Devyatyarova-Johnson M., Rees I.H., Robertson B.D., Turner M.W., Klein N.J., Jack D.L. The lipopolysaccharide structures of Salmonella enterica serovar typhimurium and Neisseria gonorrhoeae determine the attachment of human mannose-binding lectin to intact organisms. Infect. Immun. 2000, 68:3894-3899. 10.1128/IAI.68.7.3894-3899.2000.
52. Dobó J., Harmat V., Beinrohr L., Sebestyén E., Závodszky P., Gál P. MASP-1, a promiscuous complement protease: structure of its catalytic region reveals the basis of its broad specificity. J. Immunol. 2009, 183:1207-1214. 10.4049/jimmunol.0901141.
53. Dobó J., Major B., Kékesi K.a., Szabó I., Megyeri M., Hajela K., Juhász G., Závodszky P., Gál P. Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1. PLoS ONE 2011, 6:e20036. 10.1371/journal.pone.0020036.
54. Dobó J., Schroeder V., Jenny L., Cervenak L., Závodszky P., Gál P. Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation. Mol. Immunol. 2014, 61(2):69-78. 10.1016/j.molimm.2014.05.013.
55. Dommett R.M., Klein N., Turner M.W. Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006, 68:193-209. 10.1111/j.1399-0039.2006.00649.x.
56. Dornelles L.N., Pereira-Ferrari L., Messias-Reason I. Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin. Exp. Immunol. 2006, 145:463-468. 10.1111/j.1365-2249.2006.03161.x.
57. Dunkelberger J.R., Song W.-C. Complement and its role in innate and adaptive immune responses. Cell Res. 2010, 20:34-50. 10.1038/cr.2009.139.
58. Duus K., Thielens N.M., Lacroix M., Tacnet P., Frachet P., Holmskov U., Houen G. CD91 interacts with mannan-binding lectin (MBL) through the MBL-associated serine protease-binding site. FEBS J. 2010, 277:4956-4964. 10.1111/j.1742-4658.2010.07901.x.
59. Eisen D.P. Mannose-binding lectin deficiency and respiratory tract infection. J. Innate. Immun. 2010, 2:114-122. 10.1159/000228159.
60. El Saadany S.a., Ziada D.H., Farrag W., Hazaa S. Fibrosis severity and mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex in HCV-infected patients. Arab J. Gastroenterol. 2011, 12:68-73. 10.1016/j.ajg.2011.04.005.
61. Endo Y., Takahashi M., Iwaki D., Ishida Y., Nakazawa N., Kodama T., Matsuzaka T., Kanno K., Liu Y., Tsuchiya K., Kawamura I., Ikawa M., Waguri S., Wada I., Matsushita M., Schwaeble W.W.J., Fujita T. Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to Streptococcus pneumoniae infection. J. Immunol. 2012, 189:5860-5866. 10.4049/jimmunol.1200836.
62. Eurich D., Boas-Knoop S., Yahyazadeh A., Neuhaus R., Somasundaram R., Ruehl M., Puhl G., Neuhaus P., Neumann U.P., Bahra M. Role of mannose-binding lectin-2 polymorphism in the development of acute cellular rejection after transplantation for hepatitis C virus-induced liver disease. Transpl. Infect. Dis. 2012, 14:488-495. 10.1111/j.1399-3062.2012.00747.x.
63. Feinberg H., Uitdehaag J., Davies J. Crystal structure of the CUB1-EGF-CUB2 region of mannose-binding protein associated serine protease-2. EMBO J. 2003, 22:2348-2359. 10.1093/emboj/cdg236.
64. Ferreira V., Valck C., Sanchez G., Gingras a., Tzima S., Molina M.C., Sim R., Schwaeble W., Ferreira a. The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi. J. Immunol. 2004, 172:3042-3050. 10.4049/jimmunol.172.5.3042.
65. Fischer E., Ouaissi M.A., Velge P., Cornette J., Kazatchkine M.D. The trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology 1988, 299-303.
66. Frauenknecht V., Thiel S., Storm L., Meier N., Arnold M., Schmid J.-P., Saner H., Schroeder V. Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases. Clin. Exp. Immunol. 2013, 173:112-120. 10.1111/cei.12093.
67. Gabolde M., Feingold J., Besmond C. Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study. Br. Med. J. 1999, 319:1166-1167.
68. Gál P., Harmat V., Kocsis A., Bián T., Barna L., Ambrus G., Végh B., Balczer J., Sim R.B., Náray-Szabó G., Závodszky P. A true autoactivating enzyme structural insight into mannose-binding lectin-associated serine protease-2 activations. J. Biol. Chem. 2005, 280:33435-33444. 10.1074/jbc.M506051200.
69. Garcia-laorden M.I., Sole-violan J., De Castro R., Aspa J. Mannose-binding lectin - associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J. Allergy Clin. Immunol. 2008, 122(2):368-374.e2. 10.1016/j.jaci.2008.05.037.
70. Garred P., Harboe M., Oettinger T., Koch C., Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis?. Eur. J. Immunogenet. 1994, 21:125-131. 10.1111/j.1744-313X.1994.tb00183.x.
71. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard a, Høiby N., Schwartz M., Koch C. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J. Clin. Invest. 1999, 104:431-437. 10.1172/JCI6861.
72. Geha R.S., Notarangelo L.D., Casanova J.-L., Chapel H., Conley M.E., Fischer A., Hammarström L., Nonoyama S., Ochs H.D., Puck J.M., Roifman C., Seger R., Wedgwood J. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 2007, 120:776-794. 10.1016/j.jaci.2007.08.053.
73. Gibson A., Cheever A.W., Alan R., Rothfuchs A.G., Roffe E., Roffê E., Ezekowitz R.A.B., Takahashi K., Steindel M., Sher A., Báfica A. Mannose-binding lectin regulates host resistance and pathology during experimental infection with Trypanosoma cruzi. PLoS ONE 2012, 7:e47835. 10.1371/journal.pone.0047835.
74. Gingras A.R., Girija U.V., Keeble A.H., Panchal R., Mitchell D.a., Moody P.C.E., Wallis R. Structural basis of mannan-binding lectin recognition by its associated serine protease MASP-1: implications for complement activation. Structure 2011, 19:1635-1643. 10.1016/j.str.2011.08.014.
75. Granell M., Urbano-Ispizua A., Suarez B., Rovira M., Fernández-Avilés F., Martínez C., Ortega M., Uriburu C., Gaya A., Roncero J.M.A., Navarro A., Carreras E., Mensa J., Vives J., Rozman C., Montserrat E., Lozano F. Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp. Hematol. 2006, 34:1435-1441. 10.1016/j.exphem.2006.06.005.
76. Gulla K.C., Gupta K., Krarup A., Gal P., Schwaeble W.J., Sim R.B., O'Connor C.D., Hajela K. Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 2010, 129:482-495. 10.1111/j.1365-2567.2009.03200.x.
77. Gupta S., Snow R., Donnelly C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat. Med. 1999, 5:3-6.
78. Haerynck F., Van Steen K., Cattaert T., Loeys B., Van Daele S., Schelstraete P., Claes K., Van Thielen M., De Canck I., Mahachie John J.M., De Baets F. Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients. Hum. Immunol. 2012, 73:1175-1183. 10.1016/j.humimm.2012.08.010.
79. Héja D., Harmat V., Fodor K., Wilmanns M., Dobó J., Kékesi K.a., Závodszky P., Gál P., Pál G., Harmats V., Fodor K., Wilmanns M., Dobó J., Kékesi K.a., Závodszky P., Gál P., Pál G. Monospecific inhibitors show that both mannan-binding lectin-associated serine protease-1 (MASP-1) and -2 are essential for lectin pathway activation and reveal structural plasticity of MASP-2. J. Biol. Chem 2012, 287:20290-20300. 10.1074/jbc.M112.354332.
80. Héja D., Kocsis A., Dobó J., Szilágyi K., Szász R., Závodszky P., Pál G., Gál P. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:10498-10503. 10.1073/pnas.1202588109.
81. Henriksen M.L., Brandt J., Andrieu J.-P., Nielsen C., Jensen P.H., Holmskov U., Jorgensen T.J.D., Palarasah Y., Thielens N.M., Hansen S. Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system. J. Immunol. 2013, 191:6117-6127. 10.4049/jimmunol.1302121.
82. Hisano S., Matsushita M., Fujita T., Takeshita M., Iwasaki H. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis. Pathol. Int. 2007, 57:351-357. 10.1111/j.1440-1827.2007.02107.x.
83. Holmberg V., Onkamo P., Lahtela E., Lahermo P., Bedu-Addo G., Mockenhaupt F.P., Meri S. Mutations of complement lectin pathway genes MBL2 and MASP2 associated with placental malaria. Malar. J. 2012, 11:61. 10.1186/1475-2875-11-61.
84. Holmberga V., Schustera F., Ekkehart Dietzc J., Viscontia C.S., Anemanad S.D., Bienzlea U., Mockenhaupt F.P., Holmberg V., Schuster F., Dietz E., Sagarriga Visconti J.C., Anemana S.D., Bienzle U. Mannose-binding lectin variant associated with severe malaria in young African children. Microbes Infect. 2008, 10:342-348. 10.1016/j.micinf.2007.12.008.
85. Holmskov U., Thiel S., Jensenius J.C. Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 2003, 21:547-578. 10.1146/annurev.immunol.21.120601.140954.
86. Horcajada J.P., Lozano F., Muñoz A., Suarez B., Fariñas-Alvarez C., Almela M., Smithson A., Martínez E., Mallolas J., Mensa J., Gatell J.M. Polymorphic receptors of the innate immune system (MBL/MASP-2 and TLR2/4) and susceptibility to pneumococcal bacteremia in HIV-infected patients: a case-control study. Curr. HIV Res. 2009, 7:218-223.
87. Hu Y.-L., Luo F.-L., Fu J.-L., Chen T.-L., Wu S.-M., Zhou Y.-D., Zhang X.-L. Early increased ficolin-2 concentrations are associated with severity of liver inflammation and efficacy of anti-viral therapy in chronic hepatitis C patients. Scand. J. Immunol. 2013, 77:144-150. 10.1111/sji.12014.
88. Inal J., Hui K., Miot S. Complement C2 receptor inhibitor trispanning: a novel human complement inhibitory receptor. J. Immunol. 2005, 174:356-366. 10.4049/jimmunol.174.1.356.
89. Ingels C., Vanhorebeek I., Steffensen R., Derese I., Jensen L., Wouters P.J., Hermans G., Thiel S., Van den Berghe G. Lectin pathway of complement activation and relation with clinical complications in critically ill children. Pediatr. Res. 2014, 75:99-108. 10.1038/pr.2013.180.
90. Iwaki D., Kanno K., Takahashi M., Endo Y., Matsushita M., Fujita T. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway. J. Immunol. 2011, 187:3751-3758. 10.4049/jimmunol.1100280.
91. Izumo S., Umehara F., Osame M. HTLV-I-associated myelopathy. Neuropathology 2000, 20:65-68. 10.1046/j.1440-1789.2000.00320.x.
92. Jack D.L., Read R., Tenner A., Frosch M., Turner M., Klein N. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J. Infect. Dis. 2001, 184:1152-1162.
93. Jack D.L., Dodds a.W., Anwar N., Ison C.a., Law a., Frosch M., Turner M.W., Klein N.J. Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J. Immunol. 1998, 160:1346-1353.
94. Jani P.K., Kajdácsi E., Megyeri M., Dobó J., Doleschall Z., Futosi K., Tímár C.I., Mócsai A., Makó V., Gál P., Cervenak L. MASP-1 induces a unique cytokine pattern in endothelial cells: a novel link between complement system and neutrophil granulocytes. PLoS ONE 2014, 9:e87104. 10.1371/journal.pone.0087104.
95. Kahn S., Wleklinski M., Ezekowitz R.A.B., Coder D., Aruffo A., Farr A. The major surface glycoprotein of Trypanosoma cruzi amastigotes are ligands of the human serum mannose-binding protein. Infect. Immun. 1996, 64:2649-2656.
96. Kalantari P., Deoliveira R.B., Chan J., Corbett Y., Rathinam V., Stutz A., Latz E., Gazzinelli R.T., Golenbock D.T., Fitzgerald K.A. Article dual engagement of the NLRP3 and AIM2 inflammasomes by plasmodium - derived hemozoin and DNA during malaria. Cell Rep. 2013, 6:196-210. 10.1016/j.celrep.2013.12.014.
97. Kang I., Kim J.I., Chang S.G., Lee S.J., Choi S.L., Ha J., Kim S.S. Mannan-binding lectin (MBL)-associated plasma protein present in human urine inhibits calcium oxalate crystal growth. FEBS Lett. 1999, 462:89-93. 10.1016/S0014-5793(99)01509-4.
98. Kawakami M., Ihara I., Suzuki A., Harada Y. Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice. J. Immunol. 1982, 129:2198-2201.
99. Kenawy H.I., Ali Y.M., Rajakumar K., Lynch N.J., Kadioglu A., Stover C.M., Schwaeble W.J. Absence of the lectin activation pathway of complement does not increase susceptibility to Pseudomonas aeruginosa infections. Immunobiology 2012, 217:272-280. 10.1016/j.imbio.2011.10.001.
100. Kerr F.K.F., Thomas A.A.R., Wijeyewickrema L.C., Whisstock J.C., Boyd S.E., Kaiserman D., Matthews A.Y., Bird P.I., Thielens N.M., Rossi V., Pike R.N. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the. Mol. Immunol. 2008, 45:670-677. 10.1016/j.molimm.2007.07.008.
101. Kimura A., Sakaguchi E., Nonaka M. Multi-component complement system of Cnidaria: C3, Bf, and MASP genes expressed in the endodermal tissues of a sea anemone, Nematostella vectensis. Immunobiology 2009, 214:165-178. 10.1016/j.imbio.2009.01.003.
102. Kjaer T.R., Thiel S., Andersen G.R. Toward a structure-based comprehension of the lectin pathway of complement. Mol. Immunol. 2013, 56:413-422. 10.1016/j.molimm.2013.05.007.
103. Kjaer T.R., Le le T.M., Pedersen J.S., Sander B., Golas M.M., Jensenius J.C., Andersen G.R., Thiel S. Structural insights into the initiating complex of the lectin pathway of complement activation. Structure 2015, 23:342-351. 10.1016/j.str.2014.10.024.
104. Klabunde J., Uhlemann A.-C., Tebo A.E., Kimmel J., Schwarz R.T., Kremsner P.G., Kun J.F.J. Recognition of Plasmodium falciparum proteins by mannan-binding lectin, a component of the human innate immune system. Parasitol. Res. 2002, 88:113-117. 10.1007/s00436-001-0518-y.
105. Knittel T., Fellmer P., Neubauer K., Kawakami M., Grundmann A., Ramadori G. The complement-activating protease P100 is expressed by hepatocytes and is induced by IL-6 in vitro and during the acute phase reaction in vivo. Lab. Investig. 1997, 77:221-230.
106. Kocsis A., Kékesi K.a., Szász R., Végh B.M., Balczer J., Dobó J., Závodszky P., Gál P., Pál G. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation. J. Immunol. 2010, 185:4169-4178. 10.4049/jimmunol.1001819.
107. García-Laorden M.I., García-Saavedra A., de Castro F.R., Violán J.S., Rajas O., Blanquer J., Borderías L., Rodríguez-Gallego C. Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J. Allergy Clin. Immunol. 2006, 118(6):1383-1386. 10.1016/j.jaci.2006.08.004.
108. Korir J.C., Nyakoe N.K., Awinda G., Waitumbi J.N. Complement activation by merozoite antigens of Plasmodium falciparum. PLOS ONE 2014, 9. 10.1371/journal.pone.0105093.
109. Koutsounaki E., Goulielmos G.N., Koulentaki M., Choulaki C., Kouroumalis E., Galanakis E. Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients. J. Clin. Immunol. 2008, 28:495-500. 10.1007/s10875-008-9201-8.
110. Krarup A., Gulla K.C., Gál P., Hajela K., Sim R.B. The action of MBL-associated serine protease 1 (MASP1) on factor XIII and fibrinogen. Biochim. Biophys. Acta 2008, 1784:1294-1300. 10.1016/j.bbapap.2008.03.020.
111. Krarup A., Sørensen U.B.S., Matsushita M., Jensenius J.C., Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules Mannan-binding lectin, L-ficolin, and H-ficolin. Infect. Immun. 2005, 73:1052-1060. 10.1128/IAI.73.2.1052-1060.2005.
112. Krone C.L., van de Groep K., Trzciński K., Sanders E.A.M., Bogaert D. Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. Lancet. Respir. Med. 2014, 2:141-153. 10.1016/S2213-2600(13)70165-6.
113. Kuhlman M., Joiner K., Ezekowitz R.A.B. The human mannose-binding protein functions as an opsonin. J. Exp. Med. 1989, 169:1733-1745.
114. Laursen I.a., Thielens N.M., Christiansen M., Houen G. MASP interactions with plasma-derived MBL. Mol. Immunol. 2012, 52:79-87. 10.1016/j.molimm.2012.04.014.
115. Lescure F.-X., Le Loup G., Freilij H., Develoux M., Paris L., Brutus L., Pialoux G. Chagas disease: changes in knowledge and management. Lancet. Infect. Dis. 2010, 10:556-570. 10.1016/S1473-3099(10)70098-0.
116. Liu J., Ali M.a.M., Shi Y., Zhao Y., Luo F., Yu J., Xiang T., Tang J., Li D., Hu Q., Ho W., Zhang X. Specifically binding of L-ficolin to N-glycans of HCV envelope glycoproteins E1 and E2 leads to complement activation. Cell. Mol. Immunol. 2009, 6:235-244. 10.1038/cmi.2009.32.
117. Liu J., Cao C., Ma Q. Study on interaction between SARS-CoV N and MAP19, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi - Chinese. J. Cell. Mol. Immunol. 2009, 25:777-779.
118. Luo F., Sun X., Wang Y., Wang Q., Yanhong W., Pan Q., Zhang X.L. Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans. PLOS ONE 2013, 8:e73859. 10.1371/journal.pone.0073859.
119. Luty A.J.F., Kun F.J., Kremsner P.G. Mannose-binding lectin plasma levels and gene polymorphisms in Plasmodium falciparum. Malaria 1998, 178:1996-1999. 10.1086/515690.
120. Luz P.R., Boldt A.B., Grisbach C., Kun J.F.J., Velavan T.P., Messias-Reason I.J.T. Association of L-ficolin levels and FCN2 genotypes with chronic Chagas disease. PLOS ONE 2013, 8:e60237. 10.1371/journal.pone.0060237.
121. Luz P.R., Miyazaki M.I., Neto N.C., Nisihara R.M., Messias-Reason I.J. High levels of mannose-binding lectin are associated with the risk of severe cardiomyopathy in chronic Chagas disease. Int. J. Cardiol. 2010, 143:448-450. 10.1016/j.ijcard.2009.09.467.
122. Lynch N.J., Roscher S., Hartung T., Morath S., Matsushita M., Maennel D.N., Kuraya M., Fujita T., Schwaeble W.J. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-Positive bacteria, and activates the lectin pathway of complement. J. Immunol. 2004, 172:1198-1202. 10.4049/jimmunol.172.2.1198.
123. Ma Y.J., Skjoedt M.-O., Garred P. Collectin-11/MASP complex formation triggers activation of the lectin complement pathway - the fifth lectin pathway initiation complex. J. Innate Immun. 2013, 5:242-250. 10.1159/000345356.
124. Matsushita M., Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J. Exp. Med. 1992, 176:1497-1502. 10.1084/jem.176.6.1497.
125. Matsushita M., Thiel S., Jensenius J.C., Terai I., Fujita T. Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J. Immunol. 2000, 165:2637-2642. 10.4049/jimmunol.165.5.2637.
126. Megyeri M., Harmat V., Major B., Végh Á., Balczer J., Héja D., Szilágyi K., Datz D., Pál G., Závodszky P., Gál P., Dobó J. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway. J. Biol. Chem. 2013, 288:8922-8934. 10.1074/jbc.M112.446500.
127. Megyeri M., Makó V., Beinrohr L., Doleschall Z., Prohászka Z., Cervenak L., Závodszky P., Gál P. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function. J. Immunol. 2009, 183:3409-3416. 10.4049/jimmunol.0900879.
128. Melo F.M., Vasconcelos L.R.S., Silva B.S., Moura P., Cavalcanti M.S.M., Pereira L.M.M.B., Lacerda H.R. Structural polymorphism of the mannose-binding lectin 2 (MBL2) gene in HCV-infected patients with a serological marker for thyroid autoimmunity. Int. J. Immunogenet. 2009, 36:377-381. 10.1111/j.1744-313X.2009.00871.x.
129. Messias Reason I.J., Schafranski M.D., Jensenius J.C., Steffensen R. The association between mannose-binding lectin gene polymorphism and rheumatic heart disease. Hum. Immunol. 2006, 67:991-998. 10.1016/j.humimm.2006.08.296.
130. Messias-Reason I.J., Boldt A.B. Mannose-binding lectin, a multifunctional molecule of the innate immune system: biology, genetics and disease association. Genetic Predispositon to Disease 2008, 11788:119-174. Nova Science Publishers, Inc., Hauppauge, NY.
131. Mészner Z. Pneumococcal disease prevention from early infancy to old age. Orv. Hetil. 2014, 155:243-247. 10.1556/OH.2014.29753.
132. Miller C., Wilgenbusch S., Michaels M., Chi D.S., Youngberg G., Krishnaswamy G. Molecular defects in the mannose binding lectin pathway in dermatological disease: case report and literature review. Clin. Mol. Allergy 2010, 8(6):1476-7961. 10.1186/1476-7961-8-6.
133. Møller-Kristensen M., Jensenius J.C., Jensen L., Thielens N., Rossi V., Arlaud G., Thiel S. Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J. Immunol. Methods 2003, 282:159-167. 10.1016/j.jim.2003.08.012.
134. Neth O., Jack D.L., Dodds a.W., Holzel H., Klein N.J., Turner M.W. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 2000, 68:688-693. 10.1128/IAI.68.2.688-693.2000.
135. Nonaka M., Miyazawa S. Evolution of the initiating enzymes of the complement system. Genome Biol. 2001, 3(1). reviews 1001.1-1001.5.
136. Norris K.A. Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance. Infect. Immun. 1998, 66:2460-2465.
137. Norris K.A., Bradt B., Cooper N.R., So M. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. J. Immunol. 1991, 147:2240-2247.
138. Olesen H.V., Jensenius J.C., Steffensen R., Thiel S., Schiøtz P.O. The mannan-binding lectin pathway and lung disease in cystic fibrosis - disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin. Immunol. 2006, 121:324-331. 10.1016/j.clim.2006.08.014.
139. Paréj K., Hermann A., Donáth N., Závodszky P., Gál P., Dobó J. Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases. MASP-1 and MASP-2, provide evidence for heterodimer formation. Mol. Immunol. 2014, 59:1-9. 10.1016/j.molimm.2013.12.003.
140. Pavlov V.I., Skjoedt M.-O., Siow Tan Y., Rosbjerg A., Garred P., Stahl G.L. Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis. Circulation 2012, 126:2227-2235. 10.1161/CIRCULATIONAHA.112.123968.
141. Polotsky V.Y., Belisle J.T., Mikusova K., Ezekowitz R.A., Joiner K.A. Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis. 1997, 175:1159-1168. 10.1086/520354.
142. Presanis J., Hajela K., Ambrus G., Gál P., Sim R.B. Differential substrate and inhibitor profiles for human MASP-1 and MASP-2. Mol. Immunol. 2004, 40:921-929. 10.1016/j.molimm.2003.10.013.
143. Ramasawmy R., Spina G.S.G.G.S., Fae K.C., Pereira A.C., Nisihara R., Reason I.J.M., Grinberg M., Tarasoutchi F., Kalil J., Guilherme L., Kellen C., Pereira A.C., Nisihara R., Jose I., Reason M., Grinberg M., Tarasoutchi F., Guilherme L., Fae K.C., Kalil J. Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin. Vaccine Immunol. 2008, 15:932-936. 10.1128/CVI.00324-07.
144. Ren Y., Ding Q., Zhang X. Ficolins and infectious diseases. Virol. Sin. 2014, 29:25-32. 10.1007/s12250-014-3421-2.
145. Ribeiro C.H., Lynch N.J., Stover C.M., Ali Y.M., Valck C., Noya-leal F., Schwaeble W.J., Ferreira A. Deficiency in mannose-binding lectin-associated serine protease-2 does not increase susceptibility to Trypanosoma cruzi infection. Am. J. Trop. Med. Hyg. 2015, 92(2):320-324. 10.4269/ajtmh.14-0236.
146. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797. 10.1038/ni.1923.
147. Ronen R., Udpa N., Halperin E., Bafna V. Learning natural selection from the site frequency spectrum. Genetics 2013, 195:181-193. 10.1534/genetics.113.152587.
148. Rooryck C., Diaz-Font A., Osborn D.P.S., Chabchoub E., Hernandez-Hernandez V., Shamseldin H., Kenny J., Waters A., Jenkins D., Kaissi A.A., Leal G.F., Dallapiccola B., Carnevale F., Bitner-Glindzicz M., Lees M., Hennekam R., Stanier P., Burns A.J., Peeters H., Alkuraya F.S., Beales P.L. Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome. Nat. Genet. 2011, 43:197-203. 10.1038/ng.757.
149. Saeed a, Baloch K., Brown R.J.P., Wallis R., Chen L., Dexter L., McClure C.P., Shakesheff K., Thomson B.J. Mannan binding lectin-associated serine protease 1 is induced by hepatitis C virus infection and activates human hepatic stellate cells. Clin. Exp. Immunol. 2013, 174:265-273. 10.1111/cei.12174.
150. Sánchez Valdéz F.J., Pérez Brandán C., Zago M.P., Labriola C., Ferreira A., Basombrío M.Á. Trypanosoma cruzi carrying a monoallelic deletion of the calreticulin (TcCRT) gene are susceptible to complement mediated killing and defective in their metacyclogenesis. Mol. Immunol. 2013, 53:198-205. 10.1016/j.molimm.2012.08.001.
151. Santucci S.G., Gobara S., Santos C.R., Fontana C., Levin A.S. Infections in a burn intensive care unit: experience of seven years. J. Hosp. Infect. 2003, 53:6-13. 10.1053/jhin.2002.1340.
152. Sapkota B.R., Macdonald M., Berrington W.R., Misch E.A., Ranjit C., Siddiqui M.R., Kaplan G., Hawn T.R. Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes. Hum. Immunol. 2010, 71:992-998. 10.1016/j.humimm.2010.07.001.
153. Sato T., Endo Y., Matsushita M., Fujita T. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int. Immunol. 1994, 6(4):665-669. 10.1093/intimm/6.4.665.
154. Schadt E.E., Molony C., Chudin E., Hao K., Yang X., Lum P.Y., Kasarskis A., Zhang B., Wang S., Suver C., Zhu J., Millstein J., Sieberts S., Lamb J., GuhaThakurta D., Derry J., Storey J.D., Avila-Campillo I., Kruger M.J., Johnson J.M., Rohl C.a., Van Nas A., Mehrabian M., Drake T.a., Lusis A.J., Smith R.C., Guengerich F.P., Strom S.C., Schuetz E., Rushmore T.H., Ulrich R. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008, 6:1020-1032. 10.1371/journal.pbio.0060107.
155. Schafranski M.D., Pereira Ferrari L., Scherner D., Torres R., de Messias-Reason I.J., Derbli M., Pereira L., De Messias-reason I.J. Functional MASP2 gene polymorphism in patients with history of rheumatic fever. Hum. Immunol. 2008, 69:41-44. 10.1016/j.humimm.2007.11.003.
156. Schafranski M.D., Stier A., Nisihara R., Messias-Reason I.J.T. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Clin. Exp. Immunol. 2004, 138:521-525. 10.1111/j.1365-2249.2004.02645.x.
157. Schlapbach L.J., Aebi C., Otth M., Leibundgut K., Hirt A., Ammann R.A. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr. Infect. Dis. J. 2007, 26:989-994. 10.1097/INF.0b013e31811ffe6a.
158. Schlesingert L.S., Horwitz M.A. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 Fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immun. 1994, 62:280-289.
159. Segat L., Fabris A., Padovan L., Milanese M., Pirulli D., Lupo F., Salizzoni M., Amoroso A., Crovella S. MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma. J. Viral Hepat. 2008, 15:387-391. 10.1111/j.1365-2893.2007.00965.x.
160. Segat L., Silva Vasconcelos L.R., Montenegro de Melo F., Santos Silva B., Arraes L.C., Moura P., Crovella S. Association of polymorphisms in the first exon of mannose binding lectin gene (MBL2) in Brazilian patients with HCV infection. Clin. Immunol. 2007, 124:13-17. 10.1016/j.clim.2007.04.006.
161. Sirmaci A., Walsh T., Akay H., Spiliopoulos M., Sakalar Y.B., Hasanefendioğlu-Bayrak A., Duman D., Farooq A., King M.-C., Tekin M. MASP1 mutations in patients with facial, umbilical, coccygeal, and auditory findings of Carnevale, Malpuech, OSA, and Michels syndromes. Am. J. Hum. Genet. 2010, 87:679-686. 10.1016/j.ajhg.2010.09.018.
162. Skjoedt M.-O., Hummelshoj T., Palarasah Y., Honore C., Koch C., Skjodt K., Garred P. A novel mannose-binding lectin/ficolin-associated protein is highly expressed in heart and skeletal muscle tissues and inhibits complement activation. J. Biol. Chem. 2010, 285:8234-8243. 10.1074/jbc.M109.065805.
163. Skjoedt M.-O., Palarasah Y., Munthe-fog L., Jie Ma Y., Weiss G., Skjodt K., Koch C., Garred P. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation. Immunobiology 2010, 215:921-931. 10.1016/j.imbio.2009.10.006.
164. Sokolowska A., Szala A., St Swierzko A., Kozinska M., Niemiec T., Blachnio M., Augustynowicz-Kopec E., Dziadek J., Cedzynski M. Mannan-binding lectin-associated serine protease-2 (MASP-2) deficiency in two patients with pulmonary tuberculosis and one healthy control. Cell. Mol. Immunol. 2015, 12:119-121. 10.1038/cmi.2014.19.
165. Stengaard-Pedersen K., Thiel S., Gadjeva M., Møller-Kristensen M., Sørensen R., Jensen L.T., Sjøholm A.G., Fugger L., Jensenius J.C. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med. 2003, 349:554-560. 10.1056/NEJMoa022836.
166. Stover C.M., Endo Y., Takahashi M., Lynch N.J., Constantinescu C., Vorup-Jensen T., Thiel S., Friedl H., Hankeln T., Hall R., Gregory S., Fujita T., Schwaeble W. The human gene for mannan-binding lectin-associated serine protease-2 (MASP-2), the effector component of the lectin route of complement activation, is part of a tightly linked gene cluster on chromosome 1p36.2-3. Genes Immun. 2001, 2:119-127. 10.1038/sj.gene.6363745.
167. Stover C.M., Lynch N.J., Dahl M.R., Hanson S., Takahashi M., Frankenberger M., Ziegler-Heitbrock L., Eperon I., Thiel S., Schwaeble W.J. Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene. Genes Immun. 2003, 4:374-384. 10.1038/sj.gene.6363970.
168. Stover C.M., Thiel S., Thelen M., Lynch N.J., Vorup-Jensen T., Jensenius J.C., Schwaeble W.J. Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J. Immunol. 1999, 162:3481-3490.
169. Stover C.M., Schwaeble W.J., Lynch N.J., Thiel S., Speicher M.R. Assignment of the gene encoding mannan-binding lectin-associated serine protease 2 (MASP2) to human chromosome 1p36.3→p36.2 by in situ hybridization and somatic cell hybrid analysis. Cytogenet. Cell Genet. 1999, 84:148-149. 10.1159/000015243.
170. Tabouret G., Astarie-dequeker C., Demangel C., Malaga W., Bello N.F., Perez E., Guilhot C. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog. 2010, 6(10):e1001159. 10.1371/journal.ppat.1001159.
171. Takada F., Seki N., Matsuda Y., Takayama Y., Kawakami M. Localization of the genes for the 100-kDa complement-activating components of Ra-reactive factor (CRARF and Crarf) to human 3q27-q28 and mouse 16B2-B3. Genomics 1995, 25:757-759. 10.1016/0888-7543(95)80027-J.
172. Takada F., Takayama Y., Hatsuse H., Kawakami M. A new member of the C1s family of complement proteins found in a bactericidal factor, Ra-reactive factor, in human serum. Biochem. Biophys. Res. Commun. 1993, 196:1003-1009. 10.1006/bbrc.1993.2349.
173. Takahashi M., Endo Y., Fujita T., Matsushita M. A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int. Immunol. 1999, 11:859-863. 10.1093/intimm/11.5.859.
174. Tarr A.W., Urbanowicz R.a., Ball J.K. The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012, 4:1-27. 10.3390/v4010001.
175. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 2007, 44:3875-3888. 10.1016/j.molimm.2007.06.005.
176. Thiel S., Jensen L., Degn S.E., Nielsen H.J., Gál P., Dobó J., Jensenius J.C. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin. Exp. Immunol. 2012, 169:38-48. 10.1111/j.1365-2249.2012.04584.x.
177. Thiel S., Kolev M., Degn S., Steffensen R., Hansen A.G., Ruseva M., Jensenius J.C. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity. J. Immunol. 2009, 182:2939-2947. 10.4049/jimmunol.0802053.
178. Thiel S., Steffensen R., Christensen I., Ip W.K., Lau Y., Reason I., Eiberg H., Gadjeva M., Ruseva M., Jensenius J.C. Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun. 2007, 8:154-163. 10.1038/sj.gene.6364373.
179. Thiel S., Vorup-Jensen T., Stover C. A second serine protease associated with mannan-binding lectin that activates complement. Nature 1997, 386:506-510. 10.1038/386506a0.
180. Thielens N.M., Cseh S., Thiel S., Vorup-Jensen T., Rossi V., Jensenius J.C., Arlaud G.J. Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J. Immunol. 2001, 166:5068-5077. 10.4049/jimmunol.166.8.5068.
181. Thielens N.M., Tacnet-Delorme P., Arlaud G.J. Interaction of C1q and mannan-binding lectin with viruses. Immunobiology 2002, 205:563-574. 10.1078/0171-2985-00155.
182. Thimme R., Lohmann V., Weber F. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. Antiviral Res. 2006, 69:129-141. 10.1016/j.antiviral.2005.12.001.
183. Trautmann M., Lepper P.M., Haller M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am. J. Infect. Control 2005, 33:S41-S49. 10.1016/j.ajic.2005.03.006.
184. Tulio S., Faucz F., Werneck R. MASP2 gene polymorphism is associated with susceptibility to hepatitis C virus infection. Hum. Immunol. 2011, 72:912-915. 10.1016/j.humimm.2011.06.016.
185. Thye T., Niemann S., Walter K., Homolka S., Intermann D.D., Chinbua M.A., Enimil A., Gyapong J., Osei I., Owusu-Dabo E., Rusch-Gerdes S., Horstmann R.D., Ehlers S., Meyer C.G. Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis. PLoS ONE 2011, 6:e20908. 10.1371/journal.pone.0020908.
186. Unterberger C., Hanson S., Klingenhoff A., Oesterle D., Frankenberger M., Endo Y., Matsushita M., Fujita T., Schwaeble W., Weiss E.E.H., Ziegler-Heitbrock L., Stover C.M. Stat3 is involved in control of MASP2 gene expression. Biochem. Biophys. Res. Commun. 2007, 364:1022-1025. 10.1016/j.bbrc.2007.10.114.
187. Valles X., Sarrias M., Casals F., Farnós M., Piñer R., Suárez B., Morais L., Mandomando I., Sigaúque B., Roca A., Alonso P., Torres A., Thielens N., Lozano F. Genetic and structural analysis of MBL2 and MASP2 polymorphisms in south-eastern African children. Tissue Antigens 2009, 74:298-307. 10.1111/j.1399-0039.2009.01328.x.
188. Wallis R., Dodd R.B. Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations. J. Biol. Chem. 2000, 275:30962-30969. 10.1074/jbc.M004030200.
189. Walport M. Complement. First of two parts. N. Engl. J. Med 2001, 344:1058-1066.
190. Weiss G., Madsen H.O., Garred P. A novel mannose-binding lectin-associated serine protease 1/3 gene variant. Scand. J. Immunol. 2007, 65:430-434. 10.1111/j.1365-3083.2007.01925.x.
191. World Health Organization Leprosy 2012, 101:1-3.
192. World Health Organization Global Tuberculosis Report 2014, WHO Libr. Cat. Data.
193. Yongqing T., Drentin N., Duncan R.C., Wijeyewickrema L.C., Pike R.N. Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: two genes, five proteins and many functions?. Biochim. Biophys. Acta 2012, 1824(1):253-262. 10.1016/j.bbapap.2011.05.021.
194. Ytting H., Christensen I.J., Steffensen R., Alsner J., Thiel S., Jensenius J.C., Hansen U., Nielsen H.J. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer. Clin. Immunol. 2011, 73:122-127. 10.1111/j.1365-3083.2010.02480.x.
195. Ytting H., Christensen I.J., Thiel S., Jensenius J.C., Svendsen M.N., Nielsen L., Lottenburger T., Nielsen H.J. Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand. J. Immunol. 2007, 66:458-464. 10.1111/j.1365-3083.2007.01991.x.
196. Ytting H., Jarle I., Thiel S., Christian J., Jørgen H. Pre- and postoperative levels in serum of mannan-binding lectin associated serine protease-2 - a prognostic marker in colorectal cancer. Hum. Immunol. 2008, 69:414-420. 10.1016/j.humimm.2008.05.005.
197. Zhang M., Hou Y.J.Y., Cavusoglu E., Lee D.C., Steffensen R., Yang L., Bashari D., Villamil J., Moussa M., Fernaine G., Jensenius J.C., Marmur J.D., Ko W., Shevde K. MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans. Int. J. Cardiol. 2013, 166:499-504. 10.1016/j.ijcard.2011.11.032.MASP-2.
198. Zhu Y., Thangamani S., Ho B., Ding J.L. The ancient origin of the complement system. EMBO J. 2005, 24:382-394. 10.1038/sj.emboj.7600533.
199. Zundel S., Cseh S., Lacroix M., Dahl M.R., Matsushita M., Andrieu J.P., Schwaeble W.J., Jensenius J.C., Fujita T., Arlaud G.J., Thielens N.M. Characterization of recombinant mannan-binding lectin-associated serine protease (MASP)-3 suggests an activation mechanism different from that of MASP-1 and MASP-2. J. Immunol. 2004, 172(7):4342-4350. 10.4049/jimmunol.172.7.4342.